TitleDatePubMed ID
Characterization of DprE1-Mediated Benzothiazinone Resistance in Mycobacterium tuberculosis.2016 Nov27527085
Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2'-oxidase.2015 Dec 1526643218
Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase.2015 Dec 1127623058
The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis.2015 Aug25987616
Structure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studies.201525789990
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.2014 Jun 2624871036
Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity.2014 Jun 1224818517
The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis.2013 Oct24037308
Crystal structure of decaprenylphosphoryl-β- D-ribose 2'-epimerase from Mycobacterium smegmatis.2013 Mar23184707
Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors.2012 Jul 1022733761